SYS ONLINE
Supplements/Amino Acid

DL-Phenylalanine

Catecholamine precursor with mild analgesic properties.

Buy

Overview

Catecholamine precursor with mild analgesic properties.

Natural sources
  • Dietary protein from animal sources (meat, fish, eggs, dairy) and plant sources (soy, legumes, grains)
  • Free-form amino acid powders and capsules
  • Targeted pre-workout, recovery, or sleep formulations
Common forms
  • Free-form crystalline powder
  • Capsules or tablets
  • Pre-mixed recovery or hydration beverages
  • Time-release formulations

Mechanism of action

L-form is a tyrosine precursor; D-form inhibits enkephalinase.

Pathways
  • · L-form is a tyrosine precursor
  • · D-form inhibits enkephalinase

Effects on the body

Supports
Modest analgesic and antidepressant effects

Organ system effects

Brain & CNS

DL-Phenylalanine modulates monoaminergic and GABAergic tone relevant to mood and anxiety regulation.

Evidence-based benefits

Modest analgesic and antidepressant effects

Limited evidence

Potential side effects

Common
  • · GI upset
Rare
    Serious
    • · Avoid in PKU

    Drug interactions

    MAOIs
    Hypertensive crisis risk.
    severe

    Supplement interactions

    Pairs well with
    • A high-quality multivitamin
      Covers micronutrient cofactors that support most supplement pathways.
    • Omega-3 (EPA/DHA)
      Foundational anti-inflammatory support that complements most regimens.
    Avoid combining with

    No specific avoidances listed.

    Dosing & bioavailability

    Typical dose
    500–1500 mg
    Best form
    Most evidence is based on the free-form crystalline powder form.
    Timing
    Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
    With food?
    Empty stomach

    Where to buy

    Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

    Scientific evidence8Show studies
    CohortArch Psychiatr Nervenkr · 1979

    DLPA for depression

    Beckmann H, et al.

    Open trial in 27 depressed patients.

    Key findings

    Substantial improvement in 12/27 patients.

    Open study
    Systematic reviewPubMed (NLM) · 1970

    PubMed: DL-Phenylalanine — Modest analgesic and antidepressant effects

    Live PubMed search

    Live results for "DL-Phenylalanine Modest analgesic and antidepressant effects" across the PubMed/MEDLINE peer-reviewed index.

    Key findings

    Opens current human and preclinical literature matching DL-Phenylalanine and "Modest analgesic and antidepressant effects". Filter by RCT, meta-analysis, or year on the results page.

    Open study
    Systematic reviewPubMed (NLM) · 1970

    PubMed: DL-Phenylalanine — randomized controlled trial

    Live PubMed search

    Live results for "DL-Phenylalanine randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

    Key findings

    Opens current human and preclinical literature matching DL-Phenylalanine and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

    Open study
    Systematic reviewPubMed (NLM) · 1970

    PubMed: DL-Phenylalanine — meta-analysis

    Live PubMed search

    Live results for "DL-Phenylalanine meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

    Key findings

    Opens current human and preclinical literature matching DL-Phenylalanine and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

    Open study
    Systematic reviewPubMed (NLM) · 1970

    PubMed: DL-Phenylalanine — pharmacokinetics

    Live PubMed search

    Live results for "DL-Phenylalanine pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

    Key findings

    Opens current human and preclinical literature matching DL-Phenylalanine and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

    Open study
    Systematic reviewPubMed (NLM) · 1970

    PubMed: DL-Phenylalanine — safety adverse events

    Live PubMed search

    Live results for "DL-Phenylalanine safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

    Key findings

    Opens current human and preclinical literature matching DL-Phenylalanine and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

    Open study
    Systematic reviewPubMed (NLM) · 1970

    PubMed: DL-Phenylalanine — dose response

    Live PubMed search

    Live results for "DL-Phenylalanine dose response" across the PubMed/MEDLINE peer-reviewed index.

    Key findings

    Opens current human and preclinical literature matching DL-Phenylalanine and "dose response". Filter by RCT, meta-analysis, or year on the results page.

    Open study
    Systematic reviewGoogle Scholar · 1970

    Google Scholar: DL-Phenylalanine — clinical evidence

    Live Scholar search

    Cross-database citation index for DL-Phenylalanine as it relates to "clinical evidence".

    Key findings

    Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

    Open study
    Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

    Community discussion

    (0 threads)

    Share your experience or read what others have tried. Anecdotes are not medical advice.

    Sign in or create a free account to post or reply.
    Loading discussion…